Found 50 with Last Name = 'j.' and Initial = 'bm' TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 0.25nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 0.300nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 0.390nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 0.610nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 1.19nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 1.63nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 1.65nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 1.98nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 2.34nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 3.06nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 3.34nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 3.48nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 4.73nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 6.36nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 9.23nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 14nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 15nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 18nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 18nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 23nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 24nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 27nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 47nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 64nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase kinase kinase kinase 1(Homo sapiens (Human))
Blueprint Medicines
WIPO
Blueprint Medicines
WIPO
Affinity DataIC50: 121nMAssay Description:Inhibitors were dissolved in 100% DMSO at a stock concentration of 10 mM. A 100X, 10-point, 4-fold serial dilution of each inhibitor was created in 1...More data for this Ligand-Target Pair
Affinity DataEC50: 9.20nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 0.930nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 0.410nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 6.90nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 0.910nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 67nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 28nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 45nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 580nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 39nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 6.40nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 48nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 260nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 13nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 4.90nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 2.80nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 24nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 7.5nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 3.60nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 4.5nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 52nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 290nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 2nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 7.90nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
Affinity DataEC50: 2.60nMAssay Description: Using Promega’s UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by de...More data for this Ligand-Target Pair
